These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34816262)

  • 21. Comprehensive in-vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.
    Huston NC; Wan H; de Cesaris Araujo Tavares R; Wilen C; Pyle AM
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics.
    Odongo S; Okella H; Ndekezi C; Okee M; Namayanja M; Mujuni B; Sterckx YGJ; Kizito D; Radwanska M; Magez S; Ikwap K; Mwiine FN; Lutwama JJ; Ibingira C
    PLoS One; 2022; 17(12):e0279428. PubMed ID: 36548384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
    Terasaki K; Narayanan K; Makino S
    J Virol; 2023 Jul; 97(7):e0065923. PubMed ID: 37367225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evitar: designing anti-viral RNA therapies against future RNA viruses.
    Zhang D; Tian J; Wang Y; Lu J
    Bioinformatics; 2022 Apr; 38(9):2437-2443. PubMed ID: 35294970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of novel SARS-CoV-2 variants in the Netherlands.
    Urhan A; Abeel T
    Sci Rep; 2021 Mar; 11(1):6625. PubMed ID: 33758205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.
    Gupta AK; Khan MS; Choudhury S; Mukhopadhyay A; Sakshi ; Rastogi A; Thakur A; Kumari P; Kaur M; Shalu ; Saini C; Sapehia V; Barkha ; Patel PK; Bhamare KT; Kumar M
    Front Microbiol; 2020; 11():1858. PubMed ID: 32849449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semi-Supervised Pipeline for Autonomous Annotation of SARS-CoV-2 Genomes.
    Beck KL; Seabolt E; Agarwal A; Nayar G; Bianco S; Krishnareddy H; Ngo TA; Kunitomi M; Mukherjee V; Kaufman JH
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CovDif, a Tool to Visualize the Conservation between SARS-CoV-2 Genomes and Variants.
    Cedeño-Pérez LF; Gómez-Romero L
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide.
    Vale FF; Vítor JMB; Marques AT; Azevedo-Pereira JM; Anes E; Goncalves J
    Virus Res; 2021 Oct; 304():198526. PubMed ID: 34339772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of RNA sequences derived from the coronavirus genome in human cells.
    Wakida H; Kawata K; Yamaji Y; Hattori E; Tsuchiya T; Wada Y; Ozaki H; Akimitsu N
    Biochem Biophys Res Commun; 2020 Jul; 527(4):993-999. PubMed ID: 32446559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early detection of SARS-CoV-2 variants through dynamic co-mutation network surveillance.
    Huang Q; Qiu H; Bible PW; Huang Y; Zheng F; Gu J; Sun J; Hao Y; Liu Y
    Front Public Health; 2023; 11():1015969. PubMed ID: 36755900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Functional RNA Identification (FRID) Pipeline: Identification of Potential Pseudoknot-Containing RNA Elements as Therapeutic Targets for SARS-CoV-2.
    Forstmeier PC; Meyer MO; Bevilacqua PC
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants.
    Jaworski E; Langsjoen RM; Mitchell B; Judy B; Newman P; Plante JA; Plante KS; Miller AL; Zhou Y; Swetnam D; Sotcheff S; Morris V; Saada N; Machado RR; McConnell A; Widen SG; Thompson J; Dong J; Ren P; Pyles RB; Ksiazek TG; Menachery VD; Weaver SC; Routh AL
    Elife; 2021 Sep; 10():. PubMed ID: 34581669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants.
    Gand M; Vanneste K; Thomas I; Van Gucht S; Capron A; Herman P; Roosens NHC; De Keersmaecker SCJ
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33924636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.